{"id":"https://openalex.org/W4284964962","doi":"https://doi.org/10.1182/bloodadvances.2022007474","title":"Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma","display_name":"Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma","publication_year":2022,"publication_date":"2022-07-08","ids":{"openalex":"https://openalex.org/W4284964962","doi":"https://doi.org/10.1182/bloodadvances.2022007474","pmid":"https://pubmed.ncbi.nlm.nih.gov/35802461","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9631654"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2022007474","doi":"https://doi.org/10.1182/bloodadvances.2022007474","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007474","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1182/bloodadvances.2022007474","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066955735","display_name":"Jessica S Little","orcid":"https://orcid.org/0000-0001-8093-5647","observed_orcids":["https://orcid.org/0000-0001-8093-5647"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jessica S. Little","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","2Harvard Medical School, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":"https://orcid.org/0000-0001-8093-5647","affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018259576","display_name":"Muneerah M Aleissa","orcid":"https://orcid.org/0000-0003-2167-5122","observed_orcids":["https://orcid.org/0000-0003-2167-5122"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muneerah M. Aleissa","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","4Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, MA;"],"raw_orcid":"https://orcid.org/0000-0003-2167-5122","affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"4Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006024199","display_name":"Katherine Beluch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Beluch","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030286595","display_name":"Isabel H Gonzalez-Bocco","orcid":"https://orcid.org/0000-0002-2073-092X","observed_orcids":["https://orcid.org/0000-0002-2073-092X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isabel H. Gonzalez-Bocco","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","2Harvard Medical School, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011325960","display_name":"Francisco M. Marty","orcid":"https://orcid.org/0000-0002-3708-8734","observed_orcids":["https://orcid.org/0000-0002-3708-8734"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco M. Marty","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","2Harvard Medical School, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057245327","display_name":"Jennifer Manne\u2010Goehler","orcid":"https://orcid.org/0000-0001-9295-0035","observed_orcids":["https://orcid.org/0000-0001-9295-0035"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Manne-Goehler","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","2Harvard Medical School, Boston, MA;","5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0001-9295-0035","affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; and","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042918956","display_name":"Sophia Koo","orcid":"https://orcid.org/0000-0002-4973-7439","observed_orcids":["https://orcid.org/0000-0002-4973-7439"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Koo","raw_affiliation_strings":["1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","2Harvard Medical School, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036680177","display_name":"Sarah Page Hammond","orcid":"https://orcid.org/0000-0002-4271-7443","observed_orcids":["https://orcid.org/0000-0002-4271-7443"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah P. Hammond","raw_affiliation_strings":["2Harvard Medical School, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; and","6Division of Hematology and Oncology, Massachusetts General Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; and","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"6Division of Hematology and Oncology, Massachusetts General Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037526878","display_name":"Caron Alyce Jacobson","orcid":"https://orcid.org/0000-0002-0180-0654","observed_orcids":["https://orcid.org/0000-0002-0180-0654"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caron A. Jacobson","raw_affiliation_strings":["2Harvard Medical School, Boston, MA;","3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"3Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5066955735"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":6.0648,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.97804112,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"6","issue":"16","first_page":"4821","last_page":"4830"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8384000062942505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8384000062942505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.08529999852180481,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.02329999953508377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.8579999804496765},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antifungal-prophylaxis","display_name":"antifungal prophylaxis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pneumocystis-jirovecii-pneumonia","display_name":"Pneumocystis carinii pneumonia","score":0.9589999914169312},{"id":"https://openalex.org/keywords/invasive-mold-infections","display_name":"invasive mold infections","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.7829999923706055},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.9369999766349792},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8349999785423279},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cumulative-incidence","display_name":"cumulative incidence","score":0.7350000143051147},{"id":"https://openalex.org/keywords/competing-risks","display_name":"competing risks","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.7600212097167969},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.7184423804283142},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.613792359828949},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5971633195877075},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5832666158676147},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5738393068313599},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5373674035072327},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47624731063842773},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4530175030231476},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.40797269344329834},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3274601399898529},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2579472064971924},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23886248469352722},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000072742","descriptor_name":"Invasive Fungal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000072742","descriptor_name":"Invasive Fungal Infections","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D000072742","descriptor_name":"Invasive Fungal Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002452","descriptor_name":"Cell Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018941","descriptor_name":"Antigens, CD19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2022007474","doi":"https://doi.org/10.1182/bloodadvances.2022007474","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007474","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9631654","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9631654","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:35802461","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35802461","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2022007474","doi":"https://doi.org/10.1182/bloodadvances.2022007474","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007474","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W1510894502","https://openalex.org/W1849607011","https://openalex.org/W1976577798","https://openalex.org/W1984461782","https://openalex.org/W1989345554","https://openalex.org/W2018076747","https://openalex.org/W2035069664","https://openalex.org/W2082708772","https://openalex.org/W2096104385","https://openalex.org/W2114208000","https://openalex.org/W2118796952","https://openalex.org/W2141698097","https://openalex.org/W2152583091","https://openalex.org/W2161185537","https://openalex.org/W2166734004","https://openalex.org/W2166858780","https://openalex.org/W2323014766","https://openalex.org/W2339375844","https://openalex.org/W2339779592","https://openalex.org/W2341266869","https://openalex.org/W2617968907","https://openalex.org/W2750649777","https://openalex.org/W2759554330","https://openalex.org/W2766745670","https://openalex.org/W2773804840","https://openalex.org/W2775369717","https://openalex.org/W2787301955","https://openalex.org/W2793826339","https://openalex.org/W2886222856","https://openalex.org/W2890837116","https://openalex.org/W2901262057","https://openalex.org/W2903062212","https://openalex.org/W2903225254","https://openalex.org/W2905654445","https://openalex.org/W2916606137","https://openalex.org/W2943335541","https://openalex.org/W2945828741","https://openalex.org/W2967884832","https://openalex.org/W2990046520","https://openalex.org/W2992091473","https://openalex.org/W2992250822","https://openalex.org/W3015514251","https://openalex.org/W3017589029","https://openalex.org/W3037830886","https://openalex.org/W3046970338","https://openalex.org/W3047027071","https://openalex.org/W3087981485","https://openalex.org/W3089766750","https://openalex.org/W3118587398","https://openalex.org/W3120738879","https://openalex.org/W3131840940","https://openalex.org/W3204393409","https://openalex.org/W3205966883","https://openalex.org/W3211326091","https://openalex.org/W3214120935","https://openalex.org/W4200210606","https://openalex.org/W4220972968","https://openalex.org/W6638889992"],"related_works":["https://openalex.org/W4310117864","https://openalex.org/W4406952041","https://openalex.org/W4391598205","https://openalex.org/W4392722063","https://openalex.org/W4403628908","https://openalex.org/W4407307558","https://openalex.org/W4360979942","https://openalex.org/W4389232390","https://openalex.org/W4387130165","https://openalex.org/W3131840940"],"abstract_inverted_index":{"CAR":[0,39,70,216],"T-cell":[1,40,71,203,217],"therapy":[2,72,218],"has":[3,35],"revolutionized":[4],"the":[5,43,46,176,222],"treatment":[6],"of":[7,48,65,97,121,125,160,224,241],"hematologic":[8],"malignancies,":[9],"although":[10],"its":[11],"use":[12],"may":[13,246],"be":[14,248],"complicated":[15],"by":[16],"toxicities,":[17],"including":[18,140,181,193],"cytokine":[19],"release":[20],"syndrome":[21,27],"(CRS),":[22],"immune":[23],"effector":[24],"cell-associated":[25],"neurotoxicity":[26],"(ICANS),":[28],"and":[29,100,111,128,150,184,187,196,200],"infections.":[30],"Invasive":[31],"fungal":[32],"disease":[33],"(IFD)":[34],"been":[36],"reported":[37],"after":[38,190],"therapy,":[41],"but":[42],"incidence":[44,104,159],"in":[45,221,235],"absence":[47,223],"antifungal":[49,226,244],"prophylaxis":[50,54,245],"is":[51],"unknown.":[52],"Optimal":[53],"strategies":[55],"are":[56],"widely":[57],"debated.":[58],"We":[59],"performed":[60],"a":[61],"single-center":[62],"retrospective":[63],"study":[64],"280":[66,177],"adults":[67],"receiving":[68],"CD19":[69,215],"for":[73,163,219],"non-Hodgkin":[74],"lymphoma":[75],"(NHL)":[76],"from":[77],"December":[78],"2017":[79],"through":[80],"September":[81],"2021.":[82],"Patients":[83],"did":[84],"not":[85,247],"receive":[86],"routine":[87,225,243],"antiyeast":[88],"or":[89],"antimold":[90],"prophylaxis.":[91],"IFD":[92,161,208],"was":[93,166,209],"identified":[94],"between":[95],"day":[96,191],"cell":[98,130],"infusion":[99],"last":[101],"follow-up.":[102],"Cumulative":[103],"functions":[105],"were":[106,206],"calculated":[107],"at":[108],"100":[109],"days":[110],"18":[112],"months":[113],"based":[114],"on":[115],"time":[116],"to":[117,173],"IFD,":[118,139,242],"using":[119],"dates":[120],"IFD-free":[122],"death,":[123],"initiation":[124],"salvage":[126],"treatment,":[127],"hematopoietic":[129],"transplantation":[131],"as":[132],"competing":[133,164],"risks.":[134],"Eight":[135],"patients":[136,212],"(2.9%)":[137],"developed":[138],"3":[141,145,195],"Pneumocystis":[142],"jirovecii":[143],"pneumonia,":[144],"invasive":[146,152],"mold":[147],"infections":[148,154],"(IMIs),":[149],"2":[151],"yeast":[153],"(IYIs).":[155],"The":[156],"100-day":[157],"cumulative":[158],"accounting":[162],"risks":[165],"1.8%":[167],"(95%":[168],"confidence":[169],"interval":[170],"[CI],":[171],"0.8%":[172],"4.4%).":[174],"Among":[175],"patients,":[178],"early":[179],"toxicities":[180,189],"CRS":[182],"(85%)":[183],"ICANS":[185],"(55%)":[186],"late":[188],"30":[192],"grades":[194],"4":[197],"neutropenia":[198],"(41%)":[199],"low":[201,238],"CD4":[202],"count":[204],"(20%)":[205],"common.":[207],"rare":[210],"among":[211],"who":[213],"received":[214],"NHL":[220],"prophylaxis,":[227],"despite":[228],"frequent":[229],"toxicities.":[230],"These":[231],"results":[232],"suggest":[233],"that,":[234],"settings":[236],"with":[237],"institutional":[239],"rates":[240],"indicated.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":19},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-07-10T00:00:00"}